Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Recurrent Glioma
NCT02119338Unknown
- Sponsor
- St. Joseph's Hospital and Medical Center
- Start
- Feb 2014
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Open-label trial of 5-aminolevulinic acid in glioma, sponsored by St. Joseph's Hospital and Medical Center. Primary endpoint: Presence of fluorescence in tumor tissue compared to tissue with treatment effect at 1 day. Status: unknown.
02
Drugs
5-aminolevulinic acid
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02119338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119338.